Cargando…
The probiotic Bacillus subtilis BS50 decreases gastrointestinal symptoms in healthy adults: a randomized, double-blind, placebo-controlled trial
Durable spore-forming probiotics are increasingly formulated into foods, beverages, and dietary supplements. To help meet this demand, the safety and efficacy of daily supplementation of Bacillus subtilis BS50 for 6 weeks was investigated in a randomized, double-blind, placebo-controlled, parallel c...
Autores principales: | Garvey, Sean M., Mah, Eunice, Blonquist, Traci M., Kaden, Valerie N., Spears, Jessica L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590435/ https://www.ncbi.nlm.nih.gov/pubmed/36269141 http://dx.doi.org/10.1080/19490976.2022.2122668 |
Ejemplares similares
-
Preclinical Safety Assessment of Bacillus subtilis BS50 for Probiotic and Food Applications
por: Brutscher, Laura M., et al.
Publicado: (2022) -
Acute Effects of a Thermogenic Drink on Energy Expenditure
por: Mah, Eunice, et al.
Publicado: (2022) -
The Probiotic Bacillus subtilis MB40 Improves Immunity in a Porcine Model of Listeriosis
por: Garvey, Sean M., et al.
Publicado: (2023) -
Examining the Gastrointestinal and Immunomodulatory Effects of the Novel Probiotic Bacillus subtilis DE111
por: Freedman, Kimberley E., et al.
Publicado: (2021) -
A randomized, open-label, parallel pilot study investigating metabolic product kinetics of the novel ketone ester, bis-hexanoyl (R)-1,3-butanediol, over one week of ingestion in healthy adults
por: Mah, Eunice, et al.
Publicado: (2023)